Phase 4 Hypertension Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have high blood pressure (hypertension) and are willing to undergo a procedure called renal denervation, which targets the nerves around the kidneys to help lower blood pressure.
- People who are either taking medication to manage their blood pressure, or whose blood pressure readings are above certain levels — specifically, an office reading above 140/90 mmHg and a 24-hour reading above 130/80 mmHg — regardless of whether they are on blood pressure medication.
Who may not be able to join:
- People whose kidney arteries are not suitable for the renal denervation procedure — for example, if the artery is too narrow (less than 3mm wide) or too short (less than 20mm long), as determined by a special type of scan called a CT angiography.
- People whose high blood pressure is caused by another medical condition, such as a hormone-producing tumour (pheochromocytoma), overproduction of a hormone called aldosterone (hyperaldosteronism), or a significant narrowing (more than 50%) in one or both kidney arteries.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Principal Investigator: Tzung-Dau Wang, MD, PhD, National Taiwan University Hospital
Phone: 886-972651070
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
24-hour systolic blood pressure reduction (compared to baseline)
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.